1-hydroxynaphthalene
1-hydroxynaphthalene has been studied in 1 paper since 2024: 1 observational study in people. The newest paper, Mar 29, 2024: “Associations of polycyclic aromatic hydrocarbons mixtures with cardiovascular diseases mortality and all-cause mortality and the mediation role of phenotypic ageing: A time-to-event analysis”.
1 new paper in 30 daysSee all 4
“1-Hydroxynapthalene (1-NAP) (HR = 1.24, P = 0.035) and 2-Hydroxyfluorene (2-FLU) (HR = 1.25, P < 0.001) showed positive association with CVDs mortality”
None of its findings points the other way.
- 1 lab in 1 country
- Funders: China Postdoctoral Science Foundation and 2 more
- Humans1
What is 1-hydroxynaphthalene linked with?
2Studies link 1-hydroxynaphthalene with 2 measures, most often mortality (1 study) and cardiovascular disease mortality (1).
Mortality
upin humans1HR 1.15
1 study
Mortality
upin humans1HR 1.15
1-hydroxynaphthalene is linked with a higher risk of mortality in humans (controlling potential confounders) (HR = 1.15, P < 0.001).
“1-NAP (HR = 1.15, P < 0.001) and 2-FLU (HR = 1.13, P < 0.001) also showed positive association with all-cause mortality”
Humanscontrolling potential confounders
Environment international
Cardiovascular disease mortality
upin humans1HR 1.24
1 study
Cardiovascular disease mortality
upin humans1HR 1.24
1-hydroxynaphthalene is linked with a higher risk of cardiovascular disease mortality in humans (controlling potential confounders) (HR = 1.24, P = 0.035).
“1-Hydroxynapthalene (1-NAP) (HR = 1.24, P = 0.035) and 2-Hydroxyfluorene (2-FLU) (HR = 1.25, P < 0.001) showed positive association with CVDs mortality”
Humanscontrolling potential confounders
Environment international